www.bhdu.cn-夜肉伦伦影院无码 ,国产精品www夜色视频,3d动漫精品啪啪一区二区免费,久久婷婷综合缴情亚洲狠狠

<blockquote id="4uc0g"><tfoot id="4uc0g"></tfoot></blockquote>
  • <fieldset id="4uc0g"><table id="4uc0g"></table></fieldset>
  • <fieldset id="4uc0g"><menu id="4uc0g"></menu></fieldset>
  • <ul id="4uc0g"><sup id="4uc0g"></sup></ul>
    <strike id="4uc0g"></strike>
    <del id="4uc0g"></del>
    <strike id="4uc0g"></strike>
    該職位已失效,看看其他機(jī)會(huì)吧

    輝瑞制藥-(Senior) Strategic Marketing Manager-長沙

    面議
    • 長沙雨花區(qū)
    • 黃土嶺
    • 5-10年
    • 本科
    • 全職
    • 招1人

    職位描述

    Job Summary:

    The (Senior) Strategic Marketing Manager position is pivotal in response to the growing demand for advanced oncology care and the need for stringent QC measures. This role will lead MDT training, ensure COE certification, expand hospital alliances, implement QC systems, and upgrade our National Oncology Surveillance Network. By hiring this role, we aim to enhance patient safety, improve clinical outcomes, and solidify our position as a leader in oncology care. This role will bring about a transformative impact on our QC processes, ensuring alignment with National Health Commission regulations and fostering a culture of continuous improvement.

    HCP Capability Building:

    • Execute comprehensive MDT (Multidisciplinary Team) capability-building training programs in oncology to foster enhanced team collaboration and adherence to quality control (QC) processes.

    • Organize and oversee QC training for pharmacy departments, ensuring strict compliance with oncology drug management protocols and patient safety standards.

    • Deliver in-depth QC policy training sessions to ensure teams are well-versed and adherent to National Health Commission guidelines and industry-specific QC regulations.

    COE Certification Management:

    • Execute meticulous onsite inspections to assess and confirm compliance with COE certification standards.

    • Coordinate and facilitate expert committee training on COE certification criteria, promoting consistent application and interpretation across healthcare institutions.

    Hospital Coverage Expansion:

    • Drive the establishment of provincial hospital alliances and pan-cancer cancer hospital ecosystems to expand the coverage of the oncology QC system.

    • Promote collaboration and resource-sharing among hospitals to enhance overall QC capabilities and standards.

    In-Progress QC System Implementation (CDSS):

    • Advocate for the implementation of in-progress QC systems with provincial expert committees, ensuring the integration of QC standards in clinical practice.

    • Oversee system upgrades to meet QC criteria and provide comprehensive training to healthcare providers, ensuring seamless system implementation.

    National Oncology Surveillance Network Upgrade:

    • Promote the visualization of provincial QC results and facilitate quality competitions to improve provincial QC levels.

    • Lead the publication of the annual provincial QC yearbook and conduct QC report comprehension training to improve data utilization within the teams.

    • Drive the implementation of Real-World Evidence (RWE) research initiatives to support scientific validation and ongoing optimization of the oncology QC system.

    Qualifications:

    Educational Background:

    • Bachelor’s degree or higher in Medicine, Public Health, Management, Pharmacy, or a related field is highly preferred.

    Professional Experience:

    • A minimum of 6 years of experience in the pharmaceutical industry, with a background in RM, DM, KA, or RPM, and expertise in healthcare quality management or oncology-related fields is preferred.

    • Prior experience in healthcare institutions, pharmacy, or the development of medical quality control systems is advantageous.

    • Deep understanding of oncology treatment protocols and pertinent QC standards, particularly within MDT and QC contexts.

    Technical Proficiencies:

    • Extensive knowledge of National Health Commission and industry-specific oncology QC policies and standards, with the ability to design and implement robust training and certification programs.

    • Familiarity with the COE certification process and standards, coupled with experience in conducting onsite inspections or managing certification projects.

    • Proven data analysis skills and expertise in visualizing provincial QC results and generating insightful reports.

    • Strong project management and interdepartmental communication abilities, capable of managing multiple projects simultaneously and ensuring efficient execution.

    • Proficiency in office software and data analysis tools, adept at creating training materials, reports, and related documentation.

    Other Skills:

    • Exceptional communication and organizational skills, with a collaborative mindset that fosters open dialogue and promotes mutual understanding and cooperation among all stakeholders.

    • Self-motivated, solution-focused, and capable of independently managing complex projects while thriving in a multitasking environment.

    • Proficiency in English is preferred, with the ability to comprehend and communicate policy documents in both Chinese and English effectively.

    Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.

    Marketing and Market Research

    #LI-PFE
    查看全部

    工作地點(diǎn)

    長沙中維神農(nóng)大酒店

    職位發(fā)布者

    劉一飛/RODA

    當(dāng)前在線
    立即溝通
    公司Logo輝瑞制藥有限公司
    輝瑞公司(Pfizer Inc.)創(chuàng)建于1849年,總部位于美國紐約,是一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。輝瑞的使命是“為患者帶來改變其生活的突破創(chuàng)新”。在輝瑞,我們通過科學(xué)和全球資源為人們提供治療方案,以延長其生命,顯著改善其生活。在醫(yī)療衛(wèi)生產(chǎn)品的探索、研發(fā)和生產(chǎn)過程中,輝瑞始終致力于奉行嚴(yán)格的質(zhì)量、安全和價(jià)值標(biāo)準(zhǔn)。我們在全球的產(chǎn)品組合包括創(chuàng)新藥品和疫苗。每天,輝瑞在發(fā)達(dá)和新興市場的員工都在推進(jìn)人類健康,推動(dòng)疾病的預(yù)防、治療和治愈,以應(yīng)對挑戰(zhàn)我們這個(gè)時(shí)代的頑疾。輝瑞還與醫(yī)療衛(wèi)生服務(wù)方、政府和社區(qū)合作,支持并促進(jìn)世界各地的人們能夠獲得更為可靠和可承付的醫(yī)療衛(wèi)生服務(wù)。這與輝瑞作為一家全球卓越的創(chuàng)新生物制藥公司的責(zé)任是一致的。170余年來,輝瑞一直致力于為所有依賴我們的人帶來改變。輝瑞于1989年進(jìn)入中國市場。扎根中國30余年,輝瑞已成為在華主要的外資制藥公司之一。2021年是輝瑞新征程的開始。迄今已有170余年歷史的輝瑞正在邁入全新時(shí)代,成為一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。目前輝瑞在中國業(yè)務(wù)覆蓋全國300余個(gè)城市,累計(jì)投資超過15億美元,并設(shè)立了1家先進(jìn)的生產(chǎn)設(shè)施,2個(gè)研發(fā)中心(分別位于上海張江高科技園區(qū)和武漢光谷),在華有近7,000名員工分布于業(yè)務(wù)、研發(fā)和生產(chǎn)等領(lǐng)域。輝瑞在華上市了五大領(lǐng)域的高品質(zhì)創(chuàng)新產(chǎn)品,包括腫瘤、疫苗、抗感染、炎癥與免疫、罕見病等多個(gè)領(lǐng)域的處方藥和疫苗,強(qiáng)大完善的產(chǎn)品線旨在滿足生命各階段的健康需求。
    公司主頁
    免费AV在线| 国产精品久久久久久亚洲伦理| 无码精品午夜在线视频观看不卡| 内射白浆一区二区在线观看| 国产精品国产三级国产专不?| 国产综合网站| 综合色噜噜噜天天网在线观看| 色一情一区二区三区四区| 国产午夜成人免费一区| 97精品尹人久久大香线蕉|